申请人:Beecham Group p.l.c.
公开号:US05328922A1
公开(公告)日:1994-07-12
A class of compounds identified as N-(1-methyl-1H-indol-5-yl)-(2,3 or 4-pyridyl)ureas, derivatives thereof, methods for their preparation, pharmaceutical compositions containing same and their 5-HT receptor antagonist activity are believed to be of potential use in the treatment of a variety of CNS disorders are described herein.
本文描述了一类被鉴定为N-(1-甲基-1H-吲哚-5-基)-(2,3或4-吡啶基)脲类化合物,以及它们的衍生物、制备方法、含有同样化合物的药物组合物以及它们的5-HT受体拮抗活性。这些化合物被认为具有潜在用途,可用于治疗各种中枢神经系统疾病。